Advertisement
Screener

ASML HOLDING NV (ASML) Spending and interest coverage

ASML HOLDING NV (ASML) Spending and interest coverage

  • R&D / revenue · 12 months: Value 14.38%; Formula and calculation Research and development expense / revenue. Period ending 2025-12-31..
  • Stock-based compensation / revenue · 12 months: Value 0.62%; Formula and calculation Share-based compensation / revenue. Period ending 2025-12-31..
  • Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated EUR coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..

Spending and interest coverage

Overview →

Financial period ending 2025-12-31; current quote (m). Amounts retain their stated periods and units.

MetricValueFormula and calculation
R&D / revenue · 12 months14.38%Research and development expense / revenue. Period ending 2025-12-31.

4.70B ÷ 32.67B × 100 ≈ 14.38%

Stock-based compensation / revenue · 12 months0.62%Share-based compensation / revenue. Period ending 2025-12-31.

202.30M ÷ 32.67B × 100 ≈ 0.62%

Interest coverage · 12 months(m)Estimated: average term debt × dated EUR coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified.

Calculation unavailable: missing inputs remain (m).

Calculation inputs

InputAmount with unitRaw financial data
Research and development spending4.70B EURResearch and Development Expense
Revenue32.67B EURRevenue from Contract with Customer, Excluding Assessed Tax
Stock-based compensation202.30M EURShare-based Payment Arrangement, Noncash Expense
Operating income11.30B EUROperating Income (Loss)
Interest expense · reported / estimated(m)Interest Expense · Estimated expense assumptions

Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.

Calculated history

Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.

Period endingResearch and development spending (EUR)Revenue (EUR)Stock-based compensation (EUR)Operating income (EUR)Interest expense · reported / estimated (EUR)R&D / revenueSBC / revenueInterest coverageInterest expense basis
2025-12-314.70B32.67B202.30M11.30B(m)14.38%0.62%(m)(m)
2024-12-314.30B28.26B172.60M9.02B(m)15.23%0.61%(m)(m)
2023-12-313.98B27.56B134.80M9.04B152.70M14.44%0.49%59.22×Reported
2022-12-313.25B21.17B68.90M6.50B60.80M15.37%0.33%106.92×Reported
2021-12-312.55B18.61B117.50M6.75B54.60M13.69%0.63%123.63×Reported
2020-12-312.20B13.98B53.90M4.05B43.30M15.74%0.39%93.57×Reported
2019-12-311.97B11.82B74.60M2.79B36.60M16.65%0.63%76.25×Reported
2018-12-31(m)10.94B46.30M2.97B41.80M(m)0.42%70.94×Reported
2017-12-31(m)9.05B53.10M2.50B57.50M(m)0.59%43.41×Reported
2016-12-31(m)6.79B47.70M1.66B38.00M(m)0.70%43.62×Reported
2015-12-31(m)6.29B59.07M1.57B27.40M(m)0.94%57.12×Reported
2014-12-311.07B5.86B63.38M1.28B23.10M18.34%1.08%55.51×Reported
2013-12-31882.03M5.25B52.37M1.05B(m)16.82%1.00%(m)(m)
2012-12-31589.18M4.73B18.71M1.16B22.78M12.45%0.40%50.78×Reported
2011-12-31590.27M5.65B12.43M1.64B33.74M10.45%0.22%48.65×Reported
2010-12-31523.43M4.51B12.11M1.25B23.30M11.61%0.27%53.68×Reported
2009-12-31(m)1.60B13.39M-165.01M49.30M(m)0.84%-3.35×Reported
2008-12-31(m)2.95B13.54M287.05M49.90M(m)0.46%5.75×Reported
2007-12-31(m)3.77B16.51M814.70M44.71M(m)0.44%18.22×Reported

(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.